Heart therapies: scientists have succesfully designed and tested beta blockers controlled by light
- Details
- Category: Projects
-
30 Jun 2022

A research tested in zebrafish shows the potential of photopharmacology for future heart therapies more precise and with fewer side effects. The study is published in the journal Angewandte Chemie International Edition, selected as a Hot Paper.
FlyGear, a robotic device for monitoring insects automatically and accurately
- Details
- Category: Technological offers
-
15 Jun 2022

The CSIC and the Miguel Hernández University have developed a robot and its software for counting and measuring, in an automated, precise and reliable way, the transition time between life stages of fruit flies and other insects.
Patented molecules that counteract the effect of the most common anticoagulant drug
- Details
- Category: Technological offers
-
16 Mar 2022

Researchers at IQAC-CSIC have successfully tested molecules that reverse the effect of the anticoagulant heparin, used to treat patients at risk of thrombosis. These new molecules have been patented. Patients treated with heparin may need to block its effect during surgery. The only drug available nowadays has a high molecular weight and may have associated side effects.
A biomarker signature for predicting response to cancer immunotherapy
- Details
- Category: Technological offers
-
05 May 2022

The CSIC has developed, together with other institutions, a method to personalise therapeutic strategies combined with immune checkpoint inhibitors (ICIs) in cancer patients. It is based on 10 biomarkers, and facilitates the optimisation of therapeutic strategies for various types of tumours.
Miniaturized device for electrical stimulation of cell cultures
- Details
- Category: Technological offers
-
02 Mar 2022

The use of electrical stimulation in medical research is growing rapidly for its effects on cell regeneration. The CSIC, the Autonomous University of Madrid and the University of Florida have developed a miniaturised device for in vitro electrical stimulation of cells and tissues. The technology is available for further development and commercialization.